EA201270709A1 - Композиции вакцины и способы их применения - Google Patents
Композиции вакцины и способы их примененияInfo
- Publication number
- EA201270709A1 EA201270709A1 EA201270709A EA201270709A EA201270709A1 EA 201270709 A1 EA201270709 A1 EA 201270709A1 EA 201270709 A EA201270709 A EA 201270709A EA 201270709 A EA201270709 A EA 201270709A EA 201270709 A1 EA201270709 A1 EA 201270709A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- methods
- present
- gly
- pro
- animal
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 4
- 229960005486 vaccine Drugs 0.000 title abstract 3
- 241001465754 Metazoa Species 0.000 abstract 3
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 2
- QXXBUXBKXUHVQH-FMTGAZOMSA-N (2s)-2-[[(2s)-2-[[(2s,3s)-2-[[(2s)-2-[[(2s)-6-amino-2-[[(2s)-3-hydroxy-2-[[2-[[2-[[(2s)-1-[(2s)-1-[(2s)-5-oxopyrrolidine-2-carbonyl]pyrrolidine-2-carbonyl]pyrrolidine-2-carbonyl]amino]acetyl]amino]acetyl]amino]propanoyl]amino]hexanoyl]amino]-3-methylbutan Chemical compound C([C@H]1C(=O)N2CCC[C@H]2C(=O)NCC(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=2C=CC=CC=2)C(O)=O)C(C)C)CCN1C(=O)[C@@H]1CCC(=O)N1 QXXBUXBKXUHVQH-FMTGAZOMSA-N 0.000 abstract 1
- 208000024172 Cardiovascular disease Diseases 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 108010001247 head activator peptide Proteins 0.000 abstract 1
- 230000028993 immune response Effects 0.000 abstract 1
- 230000003053 immunization Effects 0.000 abstract 1
- 230000001681 protective effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
- A61K39/00119—Melanoma antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6018—Lipids, e.g. in lipopeptides
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Настоящее изобретение относится к композиции вакцины и способам вызова защитного иммунного ответа у животных против эндогенного пептида формулы pGlu-Pro-Pro-Gly-Gly-Ser-Lys-Val-Ile-Leu-Phe, причем композиция содержит иммунизирующее эффективное количество указанного пептида или его конъюгатов. Дополнительно настоящее изобретение относится к способам лечения рака, сердечно-сосудистых заболеваний и увеличению продолжительности жизни животного, причем способы включают этап, на котором животному вводят композицию вакцины настоящего изобретения.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/RU2010/000050 WO2011099882A1 (en) | 2010-02-09 | 2010-02-09 | Vaccine compositions and methods of use thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EA201270709A1 true EA201270709A1 (ru) | 2013-01-30 |
Family
ID=43302888
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EA201270709A EA201270709A1 (ru) | 2010-02-09 | 2010-02-09 | Композиции вакцины и способы их применения |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20130078268A1 (ru) |
| EA (1) | EA201270709A1 (ru) |
| IL (1) | IL221337A0 (ru) |
| WO (1) | WO2011099882A1 (ru) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6075010A (en) * | 1992-06-09 | 2000-06-13 | Neorx Corporation | Small molecular weight ligand-hexose containing clearing agents |
| DE3117934A1 (de) | 1981-05-06 | 1982-12-09 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen | Neues peptid, verfahren zu seiner gewinnung und dieses enthaltendes arzneimittel |
-
2010
- 2010-02-09 US US13/577,662 patent/US20130078268A1/en not_active Abandoned
- 2010-02-09 WO PCT/RU2010/000050 patent/WO2011099882A1/en active Application Filing
- 2010-02-09 EA EA201270709A patent/EA201270709A1/ru unknown
-
2012
- 2012-08-07 IL IL221337A patent/IL221337A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2011099882A1 (en) | 2011-08-18 |
| IL221337A0 (en) | 2012-10-31 |
| US20130078268A1 (en) | 2013-03-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1121789T1 (el) | Νεες ανοσοενισχυτικες συνθεσεις | |
| CY1119219T1 (el) | Anti-ceacam5 αντισωματα και χρησεις αυτων | |
| EA201290919A1 (ru) | Индазольные соединения и их применение | |
| UA118332C2 (uk) | Білок, що зв'язує антиген cd27l | |
| CY1120430T1 (el) | Ανασυνδυασμενες cdv συνθεσεις και χρησεις αυτων | |
| BR112012023852A2 (pt) | vacinas recombinantes do vírus da língua azul e usos das mesmas | |
| EA201001491A1 (ru) | Репликационно-дефектные вакцины и вакцинные векторы против флавивирусов | |
| DK2459216T3 (da) | Immunogene sammensætninger omfattende tlr-aktivitetsmodulatorer | |
| MX352324B (es) | Vacunas multivalentes de nanovehiculos sinteticos. | |
| EA201391597A1 (ru) | Толерогенные синтетические наноносители, уменьшающие иммунный ответ на терапевтические белки | |
| MX2013002173A (es) | Formas farmaceuticas dirigidas de epitopos multiples para la induccion de una respuesta inmunologica frente a antigenos. | |
| AR069882A1 (es) | Circovirus porcino, molecula de acido nucleico aislada que lo codifica, composicion inmunogenica que lo comprende, vector que comprende por lo menos una molecula de acido nucleico exogena que codifica una proteina de circovirus porcino y metodos para inmunizar un cerdo contra la infeccion virica o e | |
| BR112013005329A2 (pt) | variantes não lipidadas de antígenos orf2086 de neisseria meningitidis | |
| PH12017501370A1 (en) | Bivalent swine influenza virus vaccine | |
| EA201790507A1 (ru) | Способы и композиции для усиления иммунных ответов | |
| BR112013010136A2 (pt) | vacina, composição terapêutica e métodos para o tratamento ou inibição de gliblastoma | |
| EA201692279A1 (ru) | Способ уменьшения иммуногенности белка и пептида | |
| GEP201706766B (en) | Methods and compositions for vaccinating against staphylococcus aureus | |
| NZ731659A (en) | Methods of using microneedle vaccine formulations to elicit in animals protective immunity against rabies virus | |
| EA201290319A1 (ru) | Применение источника l3 и/или l5 в качестве вакцины или диагностического средства для паразитарного заболевания | |
| WO2014165164A3 (en) | Compositions and methods for treating autoimmune diseases | |
| EA201200538A1 (ru) | Арабиногалактан для повышения приобретенного иммунного ответа | |
| EA201270709A1 (ru) | Композиции вакцины и способы их применения | |
| EA202090236A1 (ru) | Иммуногенные композиции senecavirus a и способы с ними | |
| TR201907091T4 (tr) | Yeni adjuvan kompozisyonları. |